SCHEMBL4190982

SCHEMBL4190982

CC(CC1CC1)NCc1ccccc1OC(=O)Nc1cc2ccccc2s1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
EPHX1 P07099 1/20 0.33
FPR1 P21462 2/20 0.33
FPR2 P25090 2/20 0.33
HCAR1 Q9BXC0 1/20 0.33
TAS1R3 Q7RTX0 2/20 0.32
TAS1R1 Q7RTX1 2/20 0.32
CES2 O00748 1/20 0.32
OPRM1 P35372 1/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
TMIGD3 P0DMS9 1/20 0.32
ADORA1 P30542 1/20 0.32
NPY5R Q15761 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4186546 0.87 REN (0.36) HTR1ADRD2HTR2AKDM4EFPR1
SCHEMBL4197246 0.86 REN (0.36) HTR1ADRD2HTR2AKDM4EFPR1
Cyclopropane SCHEMBL4190988 0.86 EPHX1 (0.37) EPHX1HCAR1TAS1R3TAS1R1CES2
SCHEMBL4197712 0.86 NAMPT (0.36) HTR1ADRD2HTR2AFPR1FPR2
SCHEMBL4190568 0.83 GCK (0.37) HTR1ADRD2HTR2AKDM4EOPRM1
SCHEMBL4706437 0.83 KDM4E (0.35) ALDH1A1KDM4ETDP1TAS1R3TAS1R1
SCHEMBL4194935 0.83 REN (0.35) HTR1ADRD2HTR2AKDM4EFPR1
SCHEMBL4706509 0.81 OPRM1 (0.36) EPHX1FPR1FPR2HCAR1TAS1R3
Cyclohexane SCHEMBL4194020 0.77 KDM4C (0.38) FPR1FPR2HCAR1TAS1R3TAS1R1
SCHEMBL4200116 0.77 HCAR1 (0.38) HTR1ADRD2HTR2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 HTR1A 2059/4885DRD2 4825/4885HTR2A 3672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.